Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.
about
What was old is new again: using the host response to diagnose infectious disease.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical PresentationInnate Immune Molecule Surfactant Protein D Attenuates Sepsis-induced Acute Pancreatic Injury through Modulating Apoptosis and NF-κB-mediated Inflammation.Wnt5a/FZD5/CaMKII signaling pathway mediates the effect of BML-111 on inflammatory reactions in sepsisHuman genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.Management of severe sepsis: advances, challenges, and current status.The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.Antibiofilm Peptides: Potential as Broad-Spectrum AgentsIdentification of key genes in Gram‑positive and Gram‑negative sepsis using stochastic perturbation.Tumor necrosis factor-α -308G/A and -238G/A polymorphisms are associated with increased risks of sepsis: evidence from an updated meta-analysis.Sepsis Treatment Options Are Often LackingWarburg revisited: lessons for innate immunity and sepsisEffects of meglumine cyclic adenylate pretreatment on systemic inflammatory response syndrome induced by lipopolysaccharide in rats.Bioinformatics analysis to screen for critical genes between survived and non‑survived patients with sepsis
P2860
Q30376327-87532EA3-8826-4B90-9A2D-A65116DB5268Q33722631-D3ECBCBB-BE67-4625-930A-14093EADAFC4Q35079753-A0213B11-C2BC-4B3C-9CDF-BDBB10693F6EQ36346272-28B53CBD-BE33-4B87-9270-262656C685DDQ36411651-EA4D1F89-8286-4D4A-A14C-ED895ADBF2E5Q37688733-7558FA1C-CC76-45CC-82D7-80329438D6E2Q38450665-ABE2CC67-F977-492F-BEE6-756DAF69C216Q38769811-778A7AC7-33C8-491C-A531-FB806C2ADBF0Q38805599-D825364E-D963-4BCB-8751-77865586E8B6Q40132534-0F0CD5BB-F376-4300-9377-74687BACAF82Q40292042-07F79BCB-1E09-484B-9505-03E67713076CQ41224231-A65BE8C7-7FF1-4706-90EF-D8D157FFF045Q41812521-51DAE07B-4845-4251-AEDE-C6D9DA0F0C8BQ50599475-93AF261B-94E5-4839-A80C-7124D3D77AAEQ58726989-277D51AA-05B7-456A-8971-7DBED3E2A3A7
P2860
Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Barriers to the effective trea ...... , and host-directed therapies.
@ast
Barriers to the effective trea ...... , and host-directed therapies.
@en
Barriers to the effective trea ...... , and host-directed therapies.
@nl
type
label
Barriers to the effective trea ...... , and host-directed therapies.
@ast
Barriers to the effective trea ...... , and host-directed therapies.
@en
Barriers to the effective trea ...... , and host-directed therapies.
@nl
prefLabel
Barriers to the effective trea ...... , and host-directed therapies.
@ast
Barriers to the effective trea ...... , and host-directed therapies.
@en
Barriers to the effective trea ...... , and host-directed therapies.
@nl
P2093
P2860
P356
P1476
Barriers to the effective trea ...... , and host-directed therapies.
@en
P2093
John H Boyd
Ngan H Lyle
Olga M Pena
P2860
P304
P356
10.1111/NYAS.12444
P407
P577
2014-05-02T00:00:00Z